Below is Validea's guru fundamental report for PFIZER INC (PFE). Of the 22 guru strategies we follow, PFE rates highest using our Shareholder Yield Investor model based on the published strategy ...

Below is Validea's guru fundamental report for PFIZER INC (PFE). Of the 22 guru strategies we follow, PFE rates highest using our Shareholder Yield Investor model based on the published strategy ...

In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other pharma dividend stocks. The pharmaceutical industry in 2024 faced a relatively quiet year ...

In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other healthcare stocks Jim Cramer has made bold predictions about. Healthcare has been one of Jim ...

J.P. Morgan analyst Chris Schott maintained a Hold rating on Pfizer (PFE – Research Report) today and set a price target of $30.00. The company’s shares closed yesterday at $25.23. Pick the ...

In a report released today, Umer Raffat from Evercore ISI maintained a Buy rating on Pfizer (PFE – Research Report). The company’s shares closed yesterday at $25.57. Pick the best stocks and ...

Sangamo Therapeutics Inc. (SGMO) shares plunged in Tuesday's pre-market trading by over 50% after Pfizer Inc. (PFE) terminated its partnership with the company. The two were collaborating on a gene ...

As per our database, 80 hedge fund portfolios held PFE at the end of the third quarter which was 84 in the previous quarter. While we acknowledge the potential of PFE as a leading AI investment ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Pfizer (NYSE:PFE) shares traded higher in the premarket on Tuesday after the New York-based pharma giant issued its full-year 2025 guidance and reaffirmed its full-year 2024 outlook in line with ...